ArriVent BioPharma, Inc. (AVBP)
NASDAQ·Healthcare·Biotechnology
$29.85
+0.03%
Mkt Cap $1.42B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
Implied Upside
+50.8%
Consensus $45.00 vs current $29.85
NASDAQ·Healthcare·Biotechnology
$29.85
+0.03%
Mkt Cap $1.42B
Buy
7
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
+50.8%
Consensus $45.00 vs current $29.85